(Sharecast News) - AstraZeneca: Liberum upgrades to buy with a target price of 8,250p.
RELX: Berenberg reiterates buy with a target price of 1,930p.
GB Group: Berenberg reiterates buy with a target price of 670p.
Ascential: Liberum reiterates hold with a target price of 380p.
Marston's: Liberum reiterates buy with a target price of 125p.
WPP Group: Liberum reiterates buy with a target price of 1,450p.
Renew Holdings: Liberum initiates at hold with a target price of 360p.
BT Group: Deutsche Bank reiterates sell with a target price of 165p.
Kaz Minerals: Deutsche Bank reiterates hold with a target price of 560p.
RHI Magnesita: Barclays reiterates overweight with a target price of 6,040p.
AVEVA: JP Morgan reiterates overweight with a target price of 4,200p.
Begbies Traynor Group: Canaccord reiterates buy with a target price of 105p.
Stagecoach: Canaccord reiterates hold with a target price of 150p.
Synthomer: Canaccord reiterates buy with a target price of 525p.
Jupiter Fund Management: Berenberg reiterates hold with a target price of 367p.
Polymetal International: Berenberg reiterates hold with a target price of 1,140p.
Astrazeneca (AZN)
Jupiter Fund Management (JUP)
Relx (REL)
Synthomer (SYNT)
Ascential (ASCL)
Gb Group (GBG)
BT (BT.A)
WPP (WPP)
RHI Magnesita (RHIM)
Begbies (BEG)
Marstons (MARS)
Renew Holdings (RNWH)3 May 2024 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)